Skip to Content

Premarin FDA Alerts

The FDA Alert(s) below may be specifically about Premarin or relate to a group or class of drugs which include Premarin (conjugated estrogens).

MedWatch Safety Alerts are distributed by the FDA and published by Following is a list of possible medication recalls, market withdrawals, alerts and warnings. For the latest FDA MedWatch alerts, go here.

Recent FDA Alert(s) for conjugated estrogens

Premarin (conjugated estrogens)

Sep 26, 2002

Audience: Reproductive healthcare professionals

FDA and Wyeth notified healthcare professionals about safety related labeling changes to the INDICATIONS and USAGE, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, and DOSAGE and ADMINISTRATION sections of the labels. The new safety information reflects new data, primarily from the Women's Health Initiative (WHI).

More Premarin Resources